Patterns of treatment and outcome of palbociclib plus endocrine therapy in hormone receptor-positive/HER2 receptor-negative metastatic breast cancer: a real-world multicentre Italian study - Concepedia

Concepedia

Publication | Open Access

Patterns of treatment and outcome of palbociclib plus endocrine therapy in hormone receptor-positive/HER2 receptor-negative metastatic breast cancer: a real-world multicentre Italian study

DOI Full Paper Access

25

Citations

40

References

2021

Year

Raffaella Palumbo, Rosalba Torrisi, Federico Sottotetti, Daniele Presti, Anna Gambaro, Elena Collovà, A. Ferzi, Elisa Agostinetto, Cristina Teragni, Giuseppe Saltalamacchia,

Therapeutic Advances in Medical Oncology

Abstract

Our data indicate that palbociclib plus ET is active and safe in HR+/HER2- MBC, also suggesting a better performance of the combinations in earlier treatment lines.

References

	Year	Citations

Page 1